QE II Lung Tumor Bank, Canada

Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Certification Status: Approved

Registration Status: Completed

Objective: The tumor bank collects non-small cell lung cancer specimens including surgically resected lung cancer fresh tumor tissue with matched normal lung tissue, whole blood, plasma, H&E slides and tissue blocks, tissue microarrays (TMA), DNA extraction from tumor tissue, DNA extraction from blood, pathology data, molecular profiling, PD-L1 status, and clinical data including survival. The objective of the tumor bank is to provide tumor tisuue and relevant material for lung cancer research.

Registered Biobank Name	QE II Lung Tumor Bank
Biobank Leader	Dr. Zhaolin Xu
Country	Canada
Email for biobank inquiries	zxu3@dal.ca
Principal Investigator	Dr. Zhaolin Xu (PI), Dr. Drew Bethune (co-PI)
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.

Biospecimen Collected: